Yamile Rodriguez-Angeles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yamile Rodriguez-Angeles has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- David Durand
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
2 shared publications - Pia S. Pannaraj
Department of Pediatrics, University of California San Diego, La Jolla, USA
2 shared publications - Aamir Ali Syed
Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital & Research Center, Pakistan; Shaukat Khanum Memorial Cancer Hospital and Research Centre, 7A Block R-3, M.A.Johar Town, Lahore, Pakistan
1 shared publication Aamr Hammani
1 shared publication- Abbas Chabok
Centre for Clinical Research Västmanland, Uppsala University, 72189 Västerås, Sweden
1 shared publication - Abdourahmane Ndong
Department of Surgery, Saint-Louis Regional Hospital, Gaston Berger University, Saint-Louis, Senegal
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 10783
Klebsiella-dominant gut communities are associated with impeded oral rotavirus vaccine response in infants
Rotavirus gastroenteritis is the leading cause of infant diarrheal death worldwide. Oral rotavirus vaccine (RVV) prevents illness and death, but efficacy differs between high- and low-income countries and the etiologies are unclear. Here, we describe the relationship between colonization of the infant gut by commensal bacteria, inflammation, and vaccine response across a cohort of infants from Panama, Peru, and the U.S. Vaccine immunogenicity was related to community composition in the first month of life and inverse to increased relative abundance of Klebsiella . Clustering communities into gut types revealed that microbiome configurations with elevated Klebsiella or Escherichia in the first month of life were negatively associated with both seroconversion and rotavirus shedding after vaccination, suggesting potential inhibition of vaccine function or host response. Infants without RVV strain shedding displayed elevated fecal calprotectin in the first month. These results implicate microbiome-augmented infant gut inflammation as a potential impediment to RVV response.
- 15 October 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 10783
Open AccessKlebsiella-dominant gut communities are associated with impeded oral rotavirus vaccine response in infants
Rotavirus gastroenteritis is the leading cause of infant diarrheal death worldwide. Oral rotavirus vaccine (RVV) prevents illness and death, but efficacy differs between high- and low-income countries and the etiologies are unclear. Here, we describe the relationship between colonization of the infant gut by commensal bacteria, inflammation, and vaccine response across a cohort of infants from Panama, Peru, and the U.S. Vaccine immunogenicity was related to community composition in the first month of life and inverse to increased relative abundance of Klebsiella . Clustering communities into gut types revealed that microbiome configurations with elevated Klebsiella or Escherichia in the first month of life were negatively associated with both seroconversion and rotavirus shedding after vaccination, suggesting potential inhibition of vaccine function or host response. Infants without RVV strain shedding displayed elevated fecal calprotectin in the first month. These results implicate microbiome-augmented infant gut inflammation as a potential impediment to RVV response.
- Open Access
- 25 September 2026
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- p. 371-8
Concentración de lactoferrina en leche materna durante el primer año posparto en Lima Norte, Perú
Lactoferrin (LF) is a glycoprotein with antimicrobial and immunomodulatory properties that is present in human milk and plays a fundamental role in infant protection. The objective was to describe LF concentration during the first postpartum year in Northern Lima, Peru. A retrospective observational study was conducted based on a secondary analysis of 158 human milk samples from 83 mothers: 39 transition milk samples (7–14 days) and 119 mature milk samples (2–12 months). LF was quantified using ELISA. The median LF concentration in transition milk was 6.52 (IQR: 5.16–8.15) mg/mL and in mature milk was 1.01 (IQR: 0.80–1.57) mg/mL. During the mature milk periods, the values were 3.33 mg/mL (2 months), 3.27 mg/mL (3–5 months), 2.56 mg/mL (6–7 months), and 2.08 mg/mL (8–12 months). Among the 22 mothers with paired samples, the mean concentration was 7.71 ± 2.27 mg/mL in transition milk and 3.76 ± 1.06 mg/mL at 2 months. The lack of sufficient colostrum samples and the uneven availability of samples limit the complete characterization of the trajectory during the first year. The results describe a decreasing pattern in LF concentration throughout the first year of lactation.
- 25 September 2026
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- p. 371-8
Open AccessConcentración de lactoferrina en leche materna durante el primer año posparto en Lima Norte, Perú
Lactoferrin (LF) is a glycoprotein with antimicrobial and immunomodulatory properties that is present in human milk and plays a fundamental role in infant protection. The objective was to describe LF concentration during the first postpartum year in Northern Lima, Peru. A retrospective observational study was conducted based on a secondary analysis of 158 human milk samples from 83 mothers: 39 transition milk samples (7–14 days) and 119 mature milk samples (2–12 months). LF was quantified using ELISA. The median LF concentration in transition milk was 6.52 (IQR: 5.16–8.15) mg/mL and in mature milk was 1.01 (IQR: 0.80–1.57) mg/mL. During the mature milk periods, the values were 3.33 mg/mL (2 months), 3.27 mg/mL (3–5 months), 2.56 mg/mL (6–7 months), and 2.08 mg/mL (8–12 months). Among the 22 mothers with paired samples, the mean concentration was 7.71 ± 2.27 mg/mL in transition milk and 3.76 ± 1.06 mg/mL at 2 months. The lack of sufficient colostrum samples and the uneven availability of samples limit the complete characterization of the trajectory during the first year. The results describe a decreasing pattern in LF concentration throughout the first year of lactation.
- Open Access
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Open AccessEffects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study